| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Acute Kidney Injury from Intravitreal Anti-vascular Endothelial Growth Factor Drugs: A Systematic Review and Meta-analysis of Randomized Controlled Trials
|
Tsao, Yu-Chien
|
|
|
37 |
6 |
p. 843-854
|
artikel
|
| 2 |
Do the Outcomes of Clinical Efficacy Trials Matter in Regulatory Decision-Making for Biosimilars?
|
Kirsch-Stefan, Nadine
|
|
|
37 |
6 |
p. 855-871
|
artikel
|
| 3 |
Enzyme Engineering Strategies for the Bioenhancement of l-Asparaginase Used as a Biopharmaceutical
|
Miranda, Javiera
|
|
|
37 |
6 |
p. 793-811
|
artikel
|
| 4 |
Malaria Vaccines: Progress to Date
|
Stanisic, Danielle I.
|
|
|
37 |
6 |
p. 737-756
|
artikel
|
| 5 |
Neoadjuvant Immunotherapy for Non-Small Cell Lung Cancer
|
Sanber, Khaled
|
|
|
37 |
6 |
p. 775-791
|
artikel
|
| 6 |
Patients’ Perceptions of Biosimilars: A Systematic Review
|
Wu, Qiyou
|
|
|
37 |
6 |
p. 829-841
|
artikel
|
| 7 |
Real-World Clinical Outcomes of Bevacizumab-awwb Biosimilar versus Bevacizumab Reference Product in Patients with Metastatic Colorectal Cancer
|
Pham, Catherine
|
|
|
37 |
6 |
p. 891-899
|
artikel
|
| 8 |
Recurrent Clostridioides difficile Infection: Current Clinical Management and Microbiome-Based Therapies
|
Berry, Parul
|
|
|
37 |
6 |
p. 757-773
|
artikel
|
| 9 |
The PROPER Study: A 48-Week, Pan-European, Real-World Study of Biosimilar SB5 Following Transition from Reference Adalimumab in Patients with Immune‐Mediated Inflammatory Disease
|
Müller-Ladner, Ulf
|
|
|
37 |
6 |
p. 873-889
|
artikel
|
| 10 |
Treatment with Biologic Drugs in Pediatric Behçet’s Disease: A Comprehensive Analysis of the Published Data
|
Batu, Ezgi Deniz
|
|
|
37 |
6 |
p. 813-828
|
artikel
|
Tijdschrift beschrijving